I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...

The scientists significantly reduced nasal inflammation and improved the sense of smell in mice by using a vitamin D nasal ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, ...

A new study from researchers at the George Washington University has found that certain bacteria living in the nose may influence how likely someone is to get a COVID-19 infection.

Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 ...

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Neurelis, Inc., today announced details of three poster presentations at the American Academy of Neurology (AAN) Annual ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

Vistagen Therapeutics, Inc.’s VTGN share price has dipped by 10.10%, which has investors questioning if this is right time to buy.